 Elanco Animal Health Inc. ELAN, -1.23 reported Monday second-quarter profit that topped expectations and revenue that more than doubled, amid strength in the U.S. vaccine business and international markets, but provided a mixed full-year outlook. The animal health company said increased logistics costs and inflationary pressure hurt the full-year profit outlook. 